No one cares?
Depends on whether you own a functioning company or ride a screen blip.
Dr Keenan has decided she most enjoys unravelling the mysteries of chemistry. Good on her.
The take away subtleties:
- she is highly respected given her simultaneous promotion to the Board.
As Head of Drug Discovery, in a world class lab, it is Dr Keenan's thoughts that are of great value
- this transition has been planned well in advance ... classic PharmAust
The blip rider rides the blip ... oblivious to the subtleties.
Ann: Epichem new CEO and Board additions, page-4
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 16.5¢ | $345.5K | 2.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 170577 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 343944 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable